首頁師資〉專/兼任師資專長

陳玉玲

陳玉玲  (Chen, Yuh-Ling, Ph.D.)

口腔醫學研究所 副教授 

分機:5364    E-mail: yuhling@mail.ncku.edu.tw

個人網址:http://www.ncku.edu.tw/~em75813/chinese/teachers/new/T15.htm

 

專長

 

1.    分子生物學

2.    細胞生物學

3.    腫瘤生物學

 

近五年代表作

1.    Z. Yang, Y. J. Chang, H. Miyamoto, J. Ni, Y. Niu, Z. Chen, Y. L. Chen, J. L. Yao, P. A. di Sant'Agnese, C. Chang (2007) Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol. 21:343-358.

2.    E. Kim, W. L. Ma, D. L. Lin, S. Inui, Y. L. Chen, and C. Chang (2007) TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochem. Biophys. Res. Commun. 361:323–328.

3.    T. M. Hong, Y. L. Chen*, Y. Y. Wu, A. Yuan, Y. C. Chao, Y. C. Chung, M. H. Wu, S. C. Yang, S. H. Pan, J. Y. Shih, W. K. Chan, and P. C. Yang (2007) Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer. Clin. Cancer Res. 13:4759-4768. *Co-first author

4.    W. F. Chiang, S. Y. Liu, L. Y. Fang, C. N. Lin, M. H. Wu, Y. L. Chen*, and Y. T. Jin (2008) Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncology 44:325-334. *Corresponding author

5.    S. H. Hsieh, N. W. Ying, M. H. Wu, W. F. Chiang, C. L. Hsu, T. Y. Wong, Y. T. Jin, T. M. Hong, and Y. L. Chen* (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27: 3746–3753. *Corresponding author

6.    K. H. Lee, Y. G. Goan, Y. L. Chen, Z. T. Lin, and P. J. Lu (2008) The oncogenic microRNA-373 down-regulates tumor suppressor LATS2 in human esophageal cancer. (Submitted)